IL1B and COVID-19: Meanwhile, previous studies showed that patients with COVID-19 were in a pro-inflammatory status with high levels of IL-1β and other cytokines [40], and high levels of IL-6 and TNF-α were observed in COVID-19 patients requiring intensive-care-unit hospitalization [41].